Healthcare provider profile · identity verified

Leif Esbensen, MD

Family Practice · WAUKESHA, WI · NPI 1669544508

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	407	117
Amlodipine Besylate	Amlodipine Besylate	227	65
Pantoprazole Sodium	Pantoprazole Sodium	220	62
Gabapentin	Gabapentin	214	43
Rosuvastatin Calcium	Rosuvastatin Calcium	187	56
Levothyroxine Sodium	Levothyroxine Sodium	186	45
Lisinopril	Lisinopril	184	52
Losartan Potassium	Losartan Potassium	182	47
Mounjaro	Tirzepatide	181	29
Metoprolol Succinate	Metoprolol Succinate	180	54
Omeprazole	Omeprazole	165	51
Furosemide	Furosemide	154	47
Simvastatin	Simvastatin	135	31
Trazodone Hcl	Trazodone Hcl	134	32
Lorazepam	Lorazepam	133	24
Eliquis	Apixaban	119	22
Tamsulosin Hcl	Tamsulosin Hcl	118	34
Tramadol Hcl	Tramadol Hcl	116	24
Diclofenac Sodium	Diclofenac Sodium	115	36
Clonazepam	Clonazepam	110	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	108	25
Allopurinol	Allopurinol	106	24
Glimepiride	Glimepiride	106	27
Metformin Hcl	Metformin Hcl	99	31
Metformin Hcl Er	Metformin Hcl	98	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	97	21
Sertraline Hcl	Sertraline Hcl	93	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	91	25
Albuterol Sulfate Hfa	Albuterol Sulfate	86	29
Celecoxib	Celecoxib	84	21
Atenolol	Atenolol	74	21
Alprazolam	Alprazolam	73	16
Hydrochlorothiazide	Hydrochlorothiazide	73	25
Ozempic	Semaglutide	73	16
Fluoxetine Hcl	Fluoxetine Hcl	71	11
Venlafaxine Hcl Er	Venlafaxine Hcl	70	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	19
Zolpidem Tartrate	Zolpidem Tartrate	68	17
Duloxetine Hcl	Duloxetine Hcl	67	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	22
Pravastatin Sodium	Pravastatin Sodium	63	18
Carvedilol	Carvedilol	59	16
Donepezil Hcl	Donepezil Hcl	57	16
Potassium Chloride	Potassium Chloride	57	19
Valsartan	Valsartan	54	12
Clopidogrel	Clopidogrel Bisulfate	52	16
Bupropion Xl	Bupropion Hcl	51	suppressed
Warfarin Sodium	Warfarin Sodium	51	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	49	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	suppressed
Montelukast Sodium	Montelukast Sodium	45	12
Fluticasone Propionate	Fluticasone Propionate	44	14
Spironolactone	Spironolactone	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	11
Ondansetron Odt	Ondansetron	41	13
Digoxin	Digoxin	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	12
Alendronate Sodium	Alendronate Sodium	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	37	13
Fenofibrate	Fenofibrate	35	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Glipizide Er	Glipizide	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Prednisone	Prednisone	33	25
Symbicort	Budesonide/Formoterol Fumarate	33	11
Aripiprazole	Aripiprazole	31	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	31	22
Januvia	Sitagliptin Phosphate	31	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	15
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Finasteride	Finasteride	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Midodrine Hcl	Midodrine Hcl	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Colesevelam Hcl	Colesevelam Hcl	23	suppressed
Diazepam	Diazepam	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Jardiance	Empagliflozin	20	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	20
Benazepril Hcl	Benazepril Hcl	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	14
Clonidine Hcl	Clonidine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Cefuroxime	Cefuroxime Axetil	15	14
Primidone	Primidone	15	suppressed
Famotidine	Famotidine	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	12	12
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nexium	Esomeprazole Magnesium	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Linzess	Linaclotide	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error